{
    "nctId": "NCT03143894",
    "briefTitle": "Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation",
    "officialTitle": "Reducing Breast Cancer-related Fatigue and Improving Cognition With Non-Invasive Brain Stimulation",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Cancer, Cognitive Dysfunction, Fatigue",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 7,
    "primaryOutcomeMeasure": "Change on Paced Auditory Serial Attention Test (PASAT)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women, 18 years of age or older\n* Stage I-III breast cancer\n* Treatment Status: At least 6 months and no more than 5 years after the conclusion of active breast cancer therapy, including surgery, radiation therapy and (neo)adjuvant chemotherapy, if administered. NOTE: Adjuvant HER2-targeted therapy and endocrine therapy may still be ongoing at the time of study enrollment.\n* Fatigue: Moderate fatigue on most days within the past week (i.e., at least 4 out of the last 7 days), rated as \u2265 4 on a 0 (no fatigue) to 10 (worst fatigue) scale.\n* Able and willing to complete study tasks as evidenced by at least the following: fluent English speaker; hearing and language comprehension; and, sufficient literacy to complete study forms and questionnaires.\n* Patient understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.\n\nExclusion Criteria:\n\n* Evidence of recurrent breast cancer at the time of enrollment.\n* Depression or anxiety as defined either by ongoing pharmacological treatment for depression or anxiety or a HADS score on initial screening.\n* Dementia as assessed by a MMSE score on initial screening.\n* Known pregnancy or nursing.\n* Any of the following: diagnosis of schizophrenia or bipolar disorder made by a physician, seizure disorder, pacemaker, hearing aids, any metal implanted in the head, or the presence of other known current untreated causes of fatigue such as anemia or untreated hypothyroidism.\n* Use of stimulant medications, sleep medications, nicotine patch, and other drugs thought to interfere with tDCS efficacy for seven days prior to and during study participation.\n* Use of narcotic pain medication, benzodiazepines, or illicit drugs for seven days prior to and during study participation.\n* Consumption of \\>14 alcoholic drinks per week or positive screening on the CAGE.\n* Skin conditions involving open sores on the scalp that would prevent proper application of the electrodes.\n* Hairstyles that obstruct placement of the electrodes including cornrows, dreadlocks, braids or other hair accessories that cannot be removed.\n* Other medical or other condition(s) that in the opinion of the investigators might compromise the objectives of the study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}